Gilead Sciences Inc financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$24.69B $22.45B $22.13B $26.11B $30.39B $32.64B $24.89B $11.20B $9.70B $8.39B $7.95B $7.01B $5.34B $4.23B $3.03B $2.03B $1.32B $27.31B $27.28B $27.12B $0.00M
GM % Gross Margin %
85.05% 79.18% 78.07% 83.26% 85.98% 87.73% 84.78% 74.48% 74.53% 74.67% 76.48% 77.24% 78.87% 81.83% 85.68% 87.17% 87.42% 79.76% 79.26% 77.80% 0.00%
OM Operating Margin
45.43% 41.60% 42.02% 54.10% 59.44% 68.00% 61.33% 40.39% 44.31% 45.54% 49.84% 51.08% 50.40% 51.17% 54.30% 55.09% 47.36% 43.70% 40.23% 36.15% 0.00%
EPS Earnings Per Share
$0.42 $0.63 $0.84 $1.03 $1.41 $1.85 $1.93 $1.95 $2.04 $8.09 $12.61 $11.57 $8.84 $6.67 $6.63 $7.09 $7.28 $7.26 $6.72 $0.00
Div. Dividends
$2.72 $2.52 $2.28 $2.08 $1.84 $1.29 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.84 $2.92 $3.00 $0.00
PR % Payout Ratio %
38.36% 38.01% 34.18% 23.53% 15.90% 10.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 39.01% 40.22% 44.64% 0
Sha. Shares
1253.53m 1265.15m 1293.62m 1306.27m 1317.46m 1441.18m 1508.66m 1533.35m 1515.3m 1502.28m 1623.74m 1799.85m 1821.02m 1861.54m 1839.31m 1831.67m 1731.66m 1253.81m 1254.24m 0m 1246.04m
OCF Operating Cash Flow
$8.17B $9.14B $8.40B $11.90B $17.05B $21.25B $12.82B $3.11B $3.20B $3.64B $2.83B $3.08B $2.14B $1.67B $1.22B $705.64M $507.96M $11.38B $9.07B $8.01B $0.00M
FCF Free Cash Flow
$7.52B $8.32B $7.48B $11.31B $15.92B $19.58B $12.26B $2.91B $2.80B $3.51B $2.77B $2.85B $2.03B $1.59B $1.11B $657.69M $456.59M $10.81B $8.34B $8.92B $0.00M
FCFS Free Cash Flow Per Share
$5.98 $6.55 $5.76 $8.65 $12.17 $14.00 $8.06 $1.91 $1.85 $2.26 $1.62 $1.58 $1.10 $0.86 $0.61 $0.36 $0.26 $8.60 $6.65 $5.95 $0.00